Nanocarriers based on nucleic acids: An important player in the future field of nanomedicine

Currently, chemotherapy is still the main clinical treatment strategy for cancer. Although it has produced significant effects, chemotherapy also has a destructive effect on normal tissues and cells, bringing many side effects to patients. Therefore, it is necessary to study high-precision, safe and controllable treatment strategies. With the development of research, nanocarriers constructed by nucleic acids (NCNAs) with addressable and sequence specificity have caught the attention of researchers.